PDL BioPharma to Announce Fourth Quarter and Full Year 2009 Financial Results and Hold Conference Call on March 2, 2010 INCLINE VILLAGE, Nev., Feb 22, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the company will hold a conference call and webcast on
PDL BioPharma to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010 INCLINE VILLAGE, Nev., Feb 02, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will
PDL BioPharma Provides Federal Income Tax Information Regarding 2009 Dividend Payments INCLINE VILLAGE, Nev., Jan 21, 2010 /PRNewswire via COMTEX/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) today announced the allocation between dividend income and return of capital for federal income tax purposes for
